Gsa Capital Partners LLP Allakos Inc. Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
A detailed history of Gsa Capital Partners LLP transactions in Allakos Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 794,896 shares of ALLK stock, worth $842,589. This represents 0.04% of its overall portfolio holdings.
Number of Shares
794,896
Previous 710,146
11.93%
Holding current value
$842,589
Previous $710,000
26.9%
% of portfolio
0.04%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding ALLK
# of Institutions
81Shares Held
64.7MCall Options Held
47.1KPut Options Held
1K-
Bvf Inc San Francisco, CA16.6MShares$17.5 Million0.34% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$6.52 Million0.31% of portfolio
-
Deep Track Capital, LP Greenwich, CT5MShares$5.3 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$3.73 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA3.08MShares$3.26 Million0.13% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $89.8M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...